Transcriptional changes in IMR32 cells upon ISX treatment. Transcriptional changes in IMR32 cells upon ISX treatment
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
IMR32 neuroblastoma cells were treated with ISX, a novel GLI1 inducing HDAC-inhibitor
应用场景：
创建时间：
2021-04-29
相关数据集
Table_11_Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer.xlsx
Patients with EGFR-mutant non-small-cell lung cancer (NSCLC) greatly benefit from EGFR-tyrosine kinase inhibitors (EGFR-TKIs) while the prognosis of patients who lack EGFR-sensitive mutations (EGFR wi
NIAID Data Ecosystem130
RNA-Seq analysis of SK-N-BE(2) neuroblastoma cells after ARID1A and ARID1B silencing for BAF complex disruption. RNA-Seq analysis of SK-N-BE(2) neuroblastoma cells after ARID1A and ARID1B silencing for BAF complex disruption
In order to determine the transcriptomic network under the control of BAF chromatin remodeling complex in neuroblastoma cells, we performed RNA-Seq analysis on a neuroblastoma cell lines to detect tho
NIAID Data Ecosystem50
Transcriptome analysis for vorinostat-treated choriocarcinoma cells. Transcriptome analysis for vorinostat-treated choriocarcinoma cells
Choriocarcinoma is one of the rare gynecological malignancies with aggressive behavior. Vorinostat is an approved HDAC inhibitor, and HDACs play important roles in regulating gene expression and modul
NIAID Data Ecosystem10
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing
The aims of this study are to compare transcripts that are differentially expressed in the MYCN amplified compare to the MYCN non-amplified neuroblastoma cell lines, in particular, long non-coding RNA
NIAID Data Ecosystem70
Neuradapt: Structural Optimization and Transcriptomic Analysis. Neuradapt: Structural Optimization and Transcriptomic Analysis
A newly developed “branched tail” oxyquinoline, neuradapt, and its variants are an order of magnitude more effective HIF prolyl hydroxylase (HIF PHD) inhibitors than roxadustat and vadadustat in HIF1
NIAID Data Ecosystem30
